SEC Form 4 · accession 0001424422-18-000001
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anja B Krammer
Officer — President · Director
Period of report
Jan 8, 2018
Accepted (ET)
Jan 9, 2018 · 6:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $0.11 | Jan 8, 2018 | A | 1,960,000 | A | — | Jan 8, 2028 | Common stock | 1,960,000 | 1,960,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable ratably over 36 months.